Citation Impact
Citing Papers
Comparison of Two Fluid-Management Strategies in Acute Lung Injury
2006 Standout
Infection, inflammation, height, and longevity
2005 Standout
β 2 -Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model
2009
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
2016 Standout
Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation
2012
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
2009 Standout
Trade‐offs in evolutionary immunology: just what is the cost of immunity?
2000 Standout
Lung-protective ventilation strategies in acute lung injury
2003
Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome
1996
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
A Simple Multiple System Organ Failure Scoring System Predicts Mortality of Patients Who Have Sepsis Syndrome
1993
Lung Neutrophil Retention and Injury After Intestinal Ischemia/Reperfusion
1997
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis
2014
Long-Acting ??2-Agonists in Asthma
2006
Opening the microcirculation: can vasodilators be useful in sepsis?
2002
The Acute Respiratory Distress Syndrome
2000 Standout
Exercise induced bronchoconstriction in adults: evidence based diagnosis and management
2016
Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses
2003
Asthma genetics and personalised medicine
2014
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
2008 Standout
Identification of patients with acute lung injury. Predictors of mortality.
1995
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Bronchodilator responsiveness in patients with COPD
2008
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome
1999 Standout
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
2016
The correlation between asthma control and health status: the GOAL study
2006
Severe Sepsis and Septic Shock
2013 Standout
Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations
2007
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
1996 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Asthma
2017 Standout
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
GRADE guidelines: 5. Rating the quality of evidence—publication bias
2011
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Soluble form of P-selectin in plasma is elevated in acute lung injury.
1995
The development of allergic inflammation
2008 StandoutNature
Sepsis and septic shock
2018 Standout
Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.
1995
Treating Patients with Severe Sepsis
1999
Role of E-selectin in bleomycin induced lung fibrosis in mice
2000
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model
2007
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
2006
Driving Pressure and Survival in the Acute Respiratory Distress Syndrome
2015 Standout
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
2002
A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery
2013 Standout
Use of Intermittent, Intravenous Cyclophosphamide for Idiopathic Pulmonary Fibrosis
1992
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury*
2002
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Ventilator-Induced Lung Injury
2013 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Ventilator-associated lung injury
2003
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
2004
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
2009 Standout
Endotoxin after gut ischemia/reperfusion causes irreversible lung injury
1992
Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators
2007
Airway Mucus Function and Dysfunction
2010 Standout
The value of positive end-expiratory pressure and Fio2 criteria in the definition of the acute respiratory distress syndrome*
2011
The Pathophysiology and Treatment of Sepsis
2003 Standout
Partial liquid ventilation decreases serum tumor necrosis factor-α concentrations in a rat acid aspiration lung injury model
2000
Allergic Rhinitis and Sinusitis in Asthma
2006
Disseminated Intravascular Coagulation
1999 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients
1999
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
2001
Incidence and Outcomes of Acute Lung Injury
2005 Standout
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Comparison of two polymorphisms of the interleukin-1 gene family
1999
The genetics of asthma and allergic disease: a 21st century perspective
2011
The CONCEPT trial: A 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma
2005
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Delirium in Mechanically Ventilated Patients
2001 Standout
Animal models of acute lung injury
2008 Standout
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
2002 Standout
Intraluminal Airway Inflammation in Chronic Bronchitis: Characterization and Correlation with Clinical Parameters
1989
Acid-induced Lung Injury
1999
Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma
2006
Endotoxin-induced Ileal Mucosal Injury and Nitric Oxide Dysregulation Are Temporally Dissociated
2000
Acute Respiratory Distress Syndrome
2005
An Official American Thoracic Society Clinical Practice Guideline: Exercise-induced Bronchoconstriction
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Mechanical Ventilation Affects Local and Systemic Cytokines in an Animal Model of Acute Respiratory Distress Syndrome
1999
Montelukast Reduces Asthma Exacerbations in 2- to 5-Year-Old Children with Intermittent Asthma
2004
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
Acute Respiratory Distress Syndrome
2012 Standout
Pharmacogenetics and asthma: false hope or new dawn?: Table 1—
2007
Inhaled magnesium sulfate in the treatment of acute asthma
2017
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Multiple Organ Failure Syndrome in the 1990s
1994
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
2000 Standout
The Acute Respiratory Distress Syndrome
1996 Standout
Inhibition of CD18 or CD11b attenuates acute lung injury after acid instillation in rabbits
1997
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Works of Paul Dorinsky being referenced
Lung Neutrophils in the Adult Respiratory Distress Syndrome
2015
The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma
2004
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists
2004
METABOLIC CONSEQUENCES OF SEPSIS
1996
The Salmeterol Multicenter Asthma Research Trial
2006
Combination Therapy with Inhaled Long‐Acting β2‐Agonists and Inhaled Corticosteroids: A Paradigm Shift in Asthma Management
2002
Neutrophil Accumulation and Structural Changes in Nonpulmonary Organs after Acute Lung Injury Induced by Phorbol Myristate Acetate
1989
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily
2003
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma
2005
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma
2002
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study
2006
Montelukast added to fluticasone propionate does not alter inflammation or outcomes
2010
Control of airway inflammation maintained at a lower steroid dose with 100/50 μg of fluticasone propionate/salmeterol
2006
Regional blood flow distribution in endotoxin-treated dogs: Modification by ibuprofen
1994
Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are “Stepped-Down”
2008
Asthma variability in patients previously treated with β2-agonists alone
2003
The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma
2005
The Combination of Ipratropium and Albuterol Optimizes Pulmonary Function Reversibility Testing in Patients With COPD
1999
Immunologic Therapy for ARDS, Septic Shock, and Multiple-Organ Failure
1993
Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma
2006
Endotoxin-induced ileal Vo2-Do2 alterations do not correlate with the severity of ileal injury
1997
Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
2002
Mechanisms of Multiple Nonpulmonary Organ Failure in ARDS
1989
EGF-Induced Bronchial Epithelial Cells Drive Neutrophil Chemotactic and Anti-Apoptotic Activity in Asthma
2013
Ileal V˙ o 2 –D˙ o 2 Alterations Induced by Endotoxin Correlate with Severity of Mitochondrial Injury
1999
Comparison of Fluticasone Propionate–Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting β 2 -Agonists Alone
2001
Cost-effectiveness analysis of fluticasone propionate/salmeterol combination versus montelukast in the treatment of adults with asthma
2002
Multiple Organ Failure
1990
Use of Cyclophosphamide in the Therapy of Idiopathic Pulmonary Fibrosis
1986
In patients taking fluticasone propionate/salmeterol 100/50μg Diskus® for asthma, fluticasone propionate nasal spray 200μg QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis
2004
In patients taking fluticasone propionate/salmeterol 100/50μg Diskus® for asthma, the addition of fluticasone propionate nasal spray 200μg QD to treat concomitant allergic rhinitis has a safety profile comparable to the addition of montelukast 10mg QD or placebo
2004
First-line therapy with fluticasone propionate/salmeterol combination product provides superior asthma control versus montelukast or fluticasone propionate alone
2002
Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury
1993
Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
2004
Diagnosis and therapy of acute respiratory distress syndrome in adults: An international survey
1996
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves
2005
Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control
2005
Loss of asthma control when patients receiving fluticasone propionate/salmeterol 100/50μg Diskus® are “stepped-down” to fluticasone propionate, salmeterol or montelukast alone
2004
“Stepping Down” from Fluticasone Propionate/Salmeerol 100/50mcg Diskus® Results in Loss of Asthma Control: Lack of Effect of Ethnic Origin
2004
Adult Bronchiolitis
1985